Endocrinology, Vol 136, 2000-2006, Copyright © 1995 by Endocrine Society

ARTICLES

Insulin-like growth factor (IGF) I and retinoic acid induce the synthesis of IGF-binding protein 5 in rat osteoblastic cells

Y Dong and E Canalis
Department of Research and Medicine, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.

The insulin-like growth factor (IGF) regulatory system has a major impact on bone physiology. Among the modulators of IGFs, a family of structurally related proteins, the IGF-binding proteins (IGFBPs), have been shown to either potentiate or inhibit IGF actions on bone growth. However, the regulation of IGFBP expression in bone cells is not completely understood. In the present study, the expression of IGFBP-5 was analyzed in primary osteoblastic cells (Ob cells) isolated from 22- day-old fetal rat calvariae. Treatment of Ob cells with either IGF-I or all-trans-retinoic acid (RA) caused a time- and dose-dependent increase in IGFBP-5 messenger RNA (mRNA) levels, as determined by Northern blot analysis. Stimulation of IGFBP-5 mRNA was obtained at 100 nM IGF-I between 6 and 16 h (2- to 2.5-fold) and 100 nM RA between 16 and 24 h (3- to 4-fold). Concomitant treatment of Ob cells with IGF-I and RA revealed an additive effect and a 5- to 7-fold increase in IGFBP-5 mRNA levels after 16-24 h. The effect of IGF-I and RA and their combination on IGFBP-5 transcripts was similar in confluent and subconfluent cultures of Ob cells. IGF-I and RA did not change IGFBP-5 mRNA stability in Ob cells after transcription arrest with the RNA polymerase II inhibitor 5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole. IGF-I and RA at 100 nM elevated the levels of IGFBP-5 heterogenous nuclear RNA, measured by reverse transcription-polymerase chain reaction. The effect was similar to that observed on mRNA levels. IGFBP-5 from rat Ob cells appeared as a single band of 31 kilodaltons in both the conditioned medium and the extracellular matrix as determined by Western immunoblots. IGF-I and RA, both at 100 nM, increased IGFBP-5 by 2- to 3-fold after 24 h. In conclusion, IGF-I and RA modify the synthesis and secretion of IGFBP-5 in rat Ob cells through pathways that may involve increased transcription and elongation and/or altered processing of heterogenous nuclear RNA. Our data suggest that IGFBP-5 may play a role in the osteoblastic- differentiated function regulated by IGF-I and RA.

This article has been cited by other articles:

				M. A Meester-Smoor, A. C Molijn, Y. Zhao, N. A Groen, C. A H Groffen, M. Boogaard, D. van Dalsum-Verbiest, G. C Grosveld, and E. C Zwarthoff The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence J. Mol. Endocrinol., January 1, 2007; 38(1): 113 - 125. [Abstract] [Full Text] [PDF]

				B. Tanno, A. Negroni, R. Vitali, M. C. Pirozzoli, V. Cesi, C. Mancini, B. Calabretta, and G. Raschella Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms J. Biol. Chem., June 21, 2002; 277(26): 23172 - 23180. [Abstract] [Full Text] [PDF]

				Z. Fu, T. Noguchi, and H. Kato Differential regulation of IGFBP-2 and IGFBP-5 gene expression by vitamin A status in Japanese quail Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E138 - E146. [Abstract] [Full Text] [PDF]

				Z. Fu, T. Noguchi, and H. Kato Vitamin A Deficiency Reduces Insulin-Like Growth Factor (IGF)-I Gene Expression and Increases IGF-I Receptor and Insulin Receptor Gene Expression in Tissues of Japanese Quail (Coturnix coturnix japonica) J. Nutr., April 1, 2001; 131(4): 1189 - 1194. [Abstract] [Full Text]

				R. C. Pereira, A. N. Economides, and E. Canalis Bone Morphogenetic Proteins Induce Gremlin, a Protein That Limits Their Activity in Osteoblasts Endocrinology, December 1, 2000; 141(12): 4558 - 4563. [Abstract] [Full Text] [PDF]

				L.-C. C. Yeh and J. C. Lee Identification of an Osteogenic Protein-1 (Bone Morphogenetic Protein-7)-Responsive Element in the Promoter of the Rat Insulin-Like Growth Factor-Binding Protein-5 Gene Endocrinology, September 1, 2000; 141(9): 3278 - 3286. [Abstract] [Full Text] [PDF]

				V. Boonyaratanakornkit, D. D. Strong, S. Mohan, D. J. Baylink, C. A. Beck, and T. A. Linkhart Progesterone Stimulation of Human Insulin-like Growth Factor-binding Protein-5 Gene Transcription in Human Osteoblasts Is Mediated by a CACCC Sequence in the Proximal Promoter J. Biol. Chem., September 10, 1999; 274(37): 26431 - 26438. [Abstract] [Full Text] [PDF]

				B. Gabbitas and E. Canalis Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E222 - E228. [Abstract] [Full Text] [PDF]

				S. Rousse, D. Montarras, C. Pinset, and C. Dubois Up-Regulation of Insulin-Like Growth Factor Binding Protein-5 Is Independent of Muscle Cell Differentiation, Sensitive to Rapamycin, But Insensitive to Wortmannin and LY294002 Endocrinology, April 1, 1998; 139(4): 1487 - 1493. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				E. Tonner, M. C. Barber, M. T. Travers, A. Logan, and D. J. Flint Hormonal Control of Insulin-Like Growth Factor-Binding Protein-5 Production in the Involuting Mammary Gland of the Rat Endocrinology, December 1, 1997; 138(12): 5101 - 5107. [Abstract] [Full Text] [PDF]

				E. M. Zimmermann, L. Li, Y. T. Hou, M. Cannon, G. M. Christman, and K. N. Bitar IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G875 - G882. [Abstract] [Full Text] [PDF]

				L.-C. C. Yeh, M. L. Adamo, M. S. Olson, and J. C. Lee Osteogenic Protein-1 and Insulin-Like Growth Factor I Synergistically Stimulate Rat Osteoblastic Cell Differentiation and Proliferation Endocrinology, October 1, 1997; 138(10): 4181 - 4190. [Abstract] [Full Text] [PDF]

				N. Franchimont, D. Durant, and E. Canalis Interleukin-6 and Its Soluble Receptor Regulate the Expression of Insulin-Like Growth Factor Binding Protein-5 in Osteoblast Cultures Endocrinology, August 1, 1997; 138(8): 3380 - 3386. [Abstract] [Full Text] [PDF]

				T. J. Nam, W. Busby Jr., D. R. Clemmons, T. J. Nam, W. Busby Jr., and D. R. Clemmons Insulin-Like Growth Factor Binding Protein-5 Binds to Plasminogen Activator Inhibitor-I Endocrinology, July 1, 1997; 138(7): 2972 - 2983. [Abstract] [Full Text] [PDF]

				B. Gabbitas, J. M. Pash, A. M. Delany, and E. Canalis Cortisol Inhibits the Synthesis of Insulin-like Growth Factor-binding Protein-5 in Bone Cell Cultures by Transcriptional Mechanisms J. Biol. Chem., April 12, 1996; 271(15): 9033 - 9038. [Abstract] [Full Text] [PDF]

				C. Duan, S. B. Hawes, T. Prevette, and D. R. Clemmons Insulin-like Growth Factor-I (IGF-I) Regulates IGF-binding Protein-5 Synthesis through Transcriptional Activation of the Gene in Aortic Smooth Muscle Cells J. Biol. Chem., February 23, 1996; 271(8): 4280 - 4288. [Abstract] [Full Text] [PDF]

				C. Duan and D. R. Clemmons Transcription Factor AP-2 Regulates Human Insulin-like Growth Factor Binding Protein-5 Gene Expression J. Biol. Chem., October 20, 1995; 270(42): 24844 - 24851. [Abstract] [Full Text] [PDF]

				Y. Imai, A. Moralez, U. Andag, J. B. Clarke, W. H. Busby Jr., and D. R. Clemmons Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions J. Biol. Chem., June 9, 2000; 275(24): 18188 - 18194. [Abstract] [Full Text] [PDF]